Know Cancer

or
forgot password
  • cancer clinical trials in san francisco, CA

  • Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
    UCSF School of Medicine
    San Francisco, California 94143-0106
    Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma
    Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML)
    University of California, San Francisco
    San Francisco, California 94143
    Acute Myeloid Leukemia
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Lymphoma, Lymphoproliferative Disorder
    Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
    University of California San Francisco
    San Francisco, California 941104206
    Hepatocellular Carcinoma
    Study of Blood and Cheek Cell Samples From Patients With Glioma
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Brain and Central Nervous System Tumors
    Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer
    University of California San Francisco
    San Francisco, California 941104206
    Breast Cancer
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    San Francisco, California 94115
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    University of California San Francisco Medical Center-Mount Zion
    San Francisco, California 94115
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Kaiser Permanente-San Francisco

    Trial Locations
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Mount Zion
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    A Study of AMNN107 in the Treatment of Metastatic and/or Inoperable Melanoma Harboring a c-Kit Mutation
    California Pacific Medical Center California Pacific Med

    Trial Locations
    California Pacific Medical Center California Pacific Med
    University of California San Francisco UCSF Cancer & Leukima Group
    Melanoma
    A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
    University of California
    San Francisco, California 94108
    Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Leukemia, Pre-leukemic Syndromes, Monosomy 7, Bone Marrow Clonal Malformations, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia
    Ketoconazole and Dexamethasone in Prostate Cancer
    University of California, San Francisco
    San Francisco, California 94143
    Prostate Cancer
    Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4S Neuroblastoma
    I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
    University of California San Francisco (UCSF)
    San Francisco, California 94115
    Breast Neoplasms, Breast Cancer, Breast Tumors
    Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen
    University of California Med. Center
    San Francisco, California 94143
    Acute Myeloid Leukemia
    Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Adrenocortical Carcinoma, Gastrointestinal Carcinoid Tumor, Kidney Cancer, Neuroblastoma, Retinoblastoma, Sarcoma
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
    Pacific Hematology Oncology Associates
    San Francisco, California 94115
    Prostate Cancer
    Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
    Kaiser Permanente-San Francisco
    San Francisco, California 94115
    Advanced Malignant Mesothelioma, Epithelial Mesothelioma, Recurrent Malignant Mesothelioma, Sarcomatous Mesothelioma
    Ovarian Cancer Vaccine for Patients in Remission
    University of California, San Francisco
    San Francisco, California 94143
    Epithelial Ovarian Cancer
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    California Pacific Medical Center
    San Francisco, California 94115
    Pancreatic Cancer
    Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies
    Investigational Site Number 840005
    San Francisco, California 94117
    Hematological Malignancy
    Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Malignant Mesothelioma
    Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
    University of California San Francisco Medical Center-Mount Zion
    San Francisco, California 94115
    Childhood Low-grade Cerebellar Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Mixed Glioma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma
    Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma
    San Francisco VA Medical Center
    San Francisco, California 94110
    Multiple Myeloma
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    San Francisco, California 94115
    Chemotherapeutic Agent Toxicity, Colorectal Cancer, Neuropathy, Neurotoxicity
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Kaiser Permanente-San Francisco

    Trial Locations
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Mount Zion
    Breast Cancer
    Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)
    University of California, San Francisco
    San Francisco, California 94143
    Multiple Myeloma
    Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
    California Pacific Medical Center - California Campus
    San Francisco, California 94118
    Kidney Cancer
    Childhood Cancer Survivor Study
    University of California-San Francisco
    San Francisco, California 94143
    Cancer
    Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment
    Investigational Site Number 840014
    San Francisco, California 94143
    Neoplasm Malignant
    Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    University of California San Francisco Medical Center-Parnassus
    San Francisco, California 94143
    Unspecified Childhood Solid Tumor, Protocol Specific
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Leukemia
    A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
    Univeristy of San Francisco
    San Francisco, California 94143
    Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Kaiser Permanente Medical Center - San Francisco Geary Campus

    Trial Locations
    Kaiser Permanente Medical Center - San Francisco Geary Campus
    UCSF Helen Diller Family Comprehensive Cancer Center
    California Pacific Medical Center - California Campus
    Colorectal Cancer
    A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
    UCSF
    San Francisco, California 941430324
    Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma
    INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Childhood Solid Tumor, Protocol Specific
    Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
    UCSF Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Anal Cancer, Neoplasm of Uncertain Malignant Potential, Nonneoplastic Condition, Precancerous Condition
    A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma
    University of California at San Francisco
    San Francisco, California 94115
    Gastric Neoplasms, Pancreatic Neoplasms
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Kaiser Permanente-San Francisco

    Trial Locations
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Mount Zion
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 in Castration-Resistant Prostate Cancer (CRPC)
    UCSF Comprehensive Cancer Center
    San Francisco, California 94115
    Prostate Cancer
    A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
    University of California at San Francisco
    San Francisco, California 94115
    Estrogen Receptor Negative (ER-Negative) Breast Cancer, Progesterone Receptor Negative (PR-Negative) Breast Cancer, Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer, Brain Metastases
    A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma (CC# 10852)
    Cutaneous Onocology Group at the Helen Dillar Family Comprehensive Cancer Center UCSF
    San Francisco, California 94115
    Melanoma
    Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
    University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center
    San Francisco, California 94115
    Upper Aerodigestive Tract Lesions, Neoplasms, Oropharyngeal, Oropharyngeal Cancer, Neoplasms, Hypopharyngeal, Hypopharyngeal Cancer, Head and Neck Neoplasms, UADT Neoplasms, Carcinoma, Squamous Cell, Papilloma
    Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
    University of California at San Francisco
    San Francisco, California 94115
    Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Neuroendocrine Tumors of Non-Pancreatic Origin, Hormone Receptor-Positive Breast Cancer
    Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)
    University of California, San Francisco
    San Francisco, California 94143
    Diffuse Intrinsic Pontine Glioma
    Natural History Study of SCID Disorders
    University of California San Francisco Children's Hospital
    San Francisco, California 94143
    SCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis, ADA Deficiency, XSCID
    Vorinostat and Radiation Therapy Followed By Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Pontine Glioma
    Kaiser Permanente-San Francisco

    Trial Locations
    Kaiser Permanente-San Francisco
    University of California San Francisco Medical Center-Parnassus
    Childhood Mixed Glioma, Untreated Childhood Brain Stem Glioma